Milrinone Lactate

CHEMBL1200977 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

301.3 g/mol

LogP

—

Phase

4

This is the lactate salt form of milrinone used in intravenous preparations; see milrinone for full prescribing information.

Moleküler Ağırlık

301,3000 g/mol

TPSA

123,00 Å²

Terapötik Alanlar

Pain Management Asthma Insomnia Hypertension Chronic Pain Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(O)C(=O)O.Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1

InChI

InChI=1S/C12H9N3O.C3H6O3/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8;1-2(4)3(5)6/h2-6H,1H3,(H,15,16);2,4H,1H3,(H,5,6)

Molecular Formula

C15H15N3O4

HBD / HBA

3 / 6

Döndürülebilir Bağlar

2

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This is the lactate salt form of milrinone used in intravenous preparations; see milrinone for full prescribing information.

Yes, Milrinone Lactate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200977. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 172293. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Milrinone Lactate PillFYI'da

Yapı

Hızlı Veriler

Formül: C15H15N3O4
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.